Voyager Therapeutics (VYGR) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 0.1.
- Voyager Therapeutics' Asset Utilization Ratio fell 7294.09% to 0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1, marking a year-over-year decrease of 7294.09%. This contributed to the annual value of 0.21 for FY2024, which is 7804.73% down from last year.
- Latest data reveals that Voyager Therapeutics reported Asset Utilization Ratio of 0.1 as of Q3 2025, which was down 7294.09% from 0.13 recorded in Q2 2025.
- Voyager Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.77 during Q4 2023, with a 5-year trough of 0.08 in Q3 2021.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.29 (2024), whereas its average is 0.35.
- In the last 5 years, Voyager Therapeutics' Asset Utilization Ratio tumbled by 8839.84% in 2021 and then surged by 40954.14% in 2023.
- Over the past 5 years, Voyager Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.2 in 2021, then rose by 21.1% to 0.24 in 2022, then soared by 223.5% to 0.77 in 2023, then tumbled by 74.76% to 0.2 in 2024, then plummeted by 47.38% to 0.1 in 2025.
- Its last three reported values are 0.1 in Q3 2025, 0.13 for Q2 2025, and 0.18 during Q1 2025.